Dolutegravir Based Regimens: Virology/Resistance
M184V and the GEMINI Studies
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
M184V and the GEMINI Studies
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
Very Low Levels of Viral Replication for DTG/3TC Versus 3DR: The TANGO Study
Mark Underwood, Clinical Virologist and Development Investigator
Very Low Levels of Viral Replication for DTG/3TC Versus 3DR: The TANGO Study
Mark Underwood, Clinical Virologist and Development Investigator
DTG/3TC: Confirmed Virologic Withdrawals in the GEMINI-1 and -2 Studies
Nneka Nwokolo, Senior Global Medical Director
DTG/3TC: Confirmed Virologic Withdrawals in the GEMINI-1 and -2 Studies
Nneka Nwokolo, Senior Global Medical Director
DTG/3TC: Barrier to Resistance
Jan van Lunzen, Head of Translational Medical Research
DTG/3TC: Barrier to Resistance
Jan van Lunzen, Head of Translational Medical Research
Connect with our Medical Experts
Find my ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1-888-226-8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1-877-844-8872 or FDA at 1-800-332-1088 or www.fda.gov/medwatch